Interferon signature guiding therapeutic decision making: ruxolitinib as first-line therapy for severe juvenile dermatomyositis?. (17th November 2020)

Record Type:: Journal Article
Title:: Interferon signature guiding therapeutic decision making: ruxolitinib as first-line therapy for severe juvenile dermatomyositis?. (17th November 2020)
Main Title:: Interferon signature guiding therapeutic decision making: ruxolitinib as first-line therapy for severe juvenile dermatomyositis?
Authors:: Heinen, André
Schnabel, Anja
Brück, Normi
Smitka, Martin
Wolf, Christine
Lucas, Nadja
Dollinger, Stefanie
Hahn, Gabriele
Günther, Claudia
Berner, Reinhard
Lee-Kirsch, Min Ae
Schuetz, Catharina
Abstract:
Is Part Of:: Rheumatology. Volume 60:Number 4(2021)
Journal:: Rheumatology
Issue:: Volume 60:Number 4(2021)
Issue Display:: Volume 60, Issue 4 (2021)
Year:: 2021
Volume:: 60
Issue:: 4
Issue Sort Value:: 2021-0060-0004-0000
Page Start:: e136
Page End:: e138
Publication Date:: 2020-11-17
Subjects:: Rheumatism -- Periodicals
Rheumatology -- Periodicals
616.723005
Journal URLs:: http://rheumatology.oupjournals.org ↗
http://rheumatology.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗
DOI:: 10.1093/rheumatology/keaa657 ↗
Languages:: English
ISSNs:: 1462-0324
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 7960.731900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16143.xml